A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
Titel:
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
Auteur:
Ganjoo, K.N. Villalobos, V.M. Kamaya, A. Fisher, G.A. Butrynski, J.E. Morgan, J.A. Wagner, A.J. D'Adamo, D. McMillan, A. Demetri, G.D. George, S.